Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,591.90
(
0.54%
)
US TECH 100
23,499.60
(
0.60%
)
Dow Jones
46,429.49
(
0.66%
)
Brent Oil
98.57
(
2.15%
)
Bitcoin
70,968.00
(
0.64%
)
News Focus
News Focus
Post# of 257285
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 237149

Wednesday, 02/22/2023 11:13:57 AM

Wednesday, February 22, 2023 11:13:57 AM

Post# of 257285
PFE’s Elranatamab—(BCMA BsAb)—gets_FDA_priority_review_for rrMM:

https://finance.yahoo.com/news/pfizer-elranatamab-receives-fda-ema-114500184.html

A corresponding MAA was accepted for review by the EMA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today